Quantbot Technologies’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
EC
PM
FC
DCM
GPP
Quantbot Technologies's LKFT Position: Q3 2022 in Review
Quantbot Technologies sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2022, closing a stake of 1,400 shares — an estimated $78K sold.
Quantbot Technologies first reported a position in LKFT in Q4 2016 and held it in 13 quarters. The position peaked at $411K in Q4 2021. 84 funds tracked by Wall St. Rank hold LKFT as of Q3 2022.
- Quantbot Technologies reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2022 after selling out during the quarter.
- Quantbot Technologies sold 1,400 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2022, an estimated $78K.
- Quantbot Technologies first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2016 and held it in 13 quarters.
- Quantbot Technologies's Lakefront Biotherapeutics American Depositary Shares position peaked at $411K in Q4 2021.
- 84 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2022.
Based on Quantbot Technologies's 13F filing for Q3 2022, filed 7 Nov 2022.